Rough Rice (ZR Март 2025)/ ECBOT
ZR08.11.2024 20:14:59 | Изменение -0.040 | Бид4:00:00 | Предложение4:00:00 | Открыть | Максимум | Минимум | Предыдущее закрытие |
---|---|---|---|---|---|---|---|
14.620USD | -0.27% | 14.710 | 14.855 | 14.665 | 14.675 | 14.595 | 14.660 |
GlobeNewswire
22.08
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Prior...
GlobeNewswire
21.08
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in...
GlobeNewswire
14.08
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR...
GlobeNewswire
09.08
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
Newsfile Corp
09.07
Teako Mobilizes Field Crew to Copper-Cobalt-Zinc Projects Lomunda-Venna and Tydalen Utilizing Recent...
GlobeNewswire
09.07
Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmace...
GlobeNewswire
25.06
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
GlobeNewswire
20.06
Nusano to Host Virtual Event “Office Hours: Radiopharmaceuticals” on June 28, 2024
GlobeNewswire
10.06
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead C...
GlobeNewswire
05.06
TRIUMPH UNVEILS LIMITED EDITION MY25 SPEED TRIPLE 1200 RR IN COLLABORATION WITH BREITLING
GlobeNewswire
23.05
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
09.05
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire
02.05
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval fo...
GlobeNewswire
18.04
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Im...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница